Stay updated on G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes specific medical terminology related to breast cancer, while significant details about the study's design and criteria have been removed.SummaryDifference23%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check92 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.